Investor

Landec Corporation Sets Fourth Quarter 2022 Earnings Conference Call for August 10, 2022 at 2:00 p.m. PT

Retrieved on: 
Wednesday, July 27, 2022
Olive, GLOBE, Investor, Hyaluronic acid, Telephone, Solution, Health, CDMO, Webcast, Biotechnology, Company, Biomedicine, Nasdaq, Syringe, International, Pharmaceutical industry

The live webcast can be accessed via Landecs website on the Investor Events & Presentations page.

Key Points: 
  • The live webcast can be accessed via Landecs website on the Investor Events & Presentations page.
  • To participate in the conference call via telephone, dial toll-free: 1-877-407-3982 (U.S.) or 1-201-493-6780 (International).
  • Please call the conference telephone number 5-10 minutes prior to the start time so the operator can register your name and organization.
  • Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels.

ObsEva Announces Corporate Updates

Retrieved on: 
Wednesday, July 27, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Bankruptcy, SIX Swiss Exchange, Documentation, Food, U.S. Securities and Exchange Commission, Woman, SEC, New Drug Application, Risk, Royal commission, Private Securities Litigation Reform Act, NDA, Uterine fibroid, Organon, NASDAQ, Pregnancy, Achievement, Inflammation, European Commission, Review, Fertilisation, Drug development, FDA, Company, Security (finance), Medicines and Healthcare products Regulatory Agency, Birth certificate, Report, Nasdaq, Investor, PDUFA, Coronavirus, Pharmaceutical industry, Financial adviser, Kissei

53 LR of the SIX Swiss Exchange

Key Points: 
  • 53 LR of the SIX Swiss Exchange
    GENEVA, Switzerland July 27, 2022 ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel therapies for womens health, today announced that it plans to initiate a corporate restructuring and refocus the Companys development and commercialization strategy.
  • The FDAs review of the NDA is still ongoing and ObsEva has not been informed of any final decision by the agency.
  • In addition, ObsEva will assess strategic options with respect to pipeline development and the worldwide rights it holds for nolasiban, excluding China.
  • Consistent with ObsEvas plans to restructure its operations, ObsEva will initiate a mass dismissal process, pursuant to Swiss law.

Monro, Inc. Announces First Quarter Fiscal 2023 Financial Results

Retrieved on: 
Wednesday, July 27, 2022
Retail, Automotive, General Automotive, Other Automotive, Tires & Rubber, Specialty, Sale, Acquisition, Time, Environment, Corporation, ATD, Investor, Trust, Lists of disasters, U.S. Securities and Exchange Commission, Maintenance, Safe harbor, Forward-looking statement, Partnership, Private Securities Litigation Reform Act, Phrase, COVID-19, Wholesaling, NASDAQ, GAAP, Weather, Professional, Share repurchase, Unemployment, Company, Acceleration, Nasdaq, Annual report, EPS, Growth, Public expenditure, Comparable, Video game, Security (finance), Retail, Bank, Risk management

Sales for the first quarter of the fiscal year ending March 25, 2023 (fiscal 2023) increased 2.3% to $349.5 million, as compared to $341.8 million for the first quarter of the fiscal year ended March 26, 2022 (fiscal 2022).

Key Points: 
  • Sales for the first quarter of the fiscal year ending March 25, 2023 (fiscal 2023) increased 2.3% to $349.5 million, as compared to $341.8 million for the first quarter of the fiscal year ended March 26, 2022 (fiscal 2022).
  • Interest expense was $5.7 million for the first quarter of fiscal 2023, as compared to $6.9 million for the first quarter of fiscal 2022, principally due to a decrease in weighted average debt.
  • Diluted earnings per share for the first quarter of fiscal 2023 was $.37, compared to $.46 in the first quarter of fiscal 2022.
  • Monro is not providing fiscal 2023 financial guidance at this time but will provide perspective on its outlook for fiscal 2023 during its earnings conference call.

DocGo to Announce Second Quarter 2022 Results on Monday, August 8

Retrieved on: 
Wednesday, July 27, 2022
Apps, Applications, Technology, Mobile, Wireless, Health Technology, Telemedicine, Virtual Medicine, Other Health, Health, General Health, Consumer Electronics, Health, Conference, MHealth, Webcast, Solution, Workplace, Conference call, Investor, Transport, Patient, Health insurance

DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services and integrated ambulance medical transportation solutions, today announced that the company will report results for the second quarter ended June 30, 2022 after the markets close on Monday, August 8.

Key Points: 
  • DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services and integrated ambulance medical transportation solutions, today announced that the company will report results for the second quarter ended June 30, 2022 after the markets close on Monday, August 8.
  • Conference call and webcast details:
    The webcast can be accessed under Events on the Investors section of the companys website, https://ir.docgo.com/ .
  • DocGo is a leading provider of last-mile mobile health services and integrated ambulance medical transportation solutions.
  • Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care.

SEA & SHORELINE, NORTH CAROLINA COASTAL FEDERATION, AND TOWN OF MOREHEAD CITY PARTNER TO RESTORE SUGARLOAF ISLAND IN MOREHEAD CITY, NC

Retrieved on: 
Wednesday, July 27, 2022
Erosion, WADS, Tennessee Intercollegiate State Legislature, Recreation, North Carolina General Assembly of 1836–1837, Water quality, Instagram, North Carolina Coastal Federation, Tree, Student, Social media, Associate, State legislature, Partnership, Town, City, YouTube, Government, Method, LinkedIn, Heart, Sea, LLC, Investor, Federation, Dredging, Aquaculture, Seaweed, Facebook

MOREHEAD CITY, N.C., July 27, 2022 /PRNewswire/ -- Today, aquatic restoration specialists Sea & Shoreline, the North Carolina Coastal Federation, and the Town of Morehead City, NC announced a partnership to increase the resiliency of downtown Morehead City, NC by protecting nearby Sugarloaf Island from continual shoreline erosion. The project team is working with Quible & Associates and local experts to identify and design the best shoreline stabilization methods for the island that balance shoreline protection, public uses, and natural resource conservation. One of the methods being considered is a hybrid approach utilizing offshore wave attenuation devices (WADs) to reduce erosion, seagrass plantings to stabilize the sediment and create essential fish habitat, and a living shoreline to build salt marsh and upland vegetation. The $2 million project is being funded by the NC state legislature. Construction is expected to begin later this year.

Key Points: 
  • MOREHEAD CITY, N.C., July 27, 2022 /PRNewswire/ -- Today, aquatic restoration specialists Sea & Shoreline , the North Carolina Coastal Federation , and the Town of Morehead City, NC announced a partnership to increase the resiliency of downtown Morehead City, NC by protecting nearby Sugarloaf Island from continual shoreline erosion.
  • We're looking forward to working closely with the professionals from Sea & Shoreline and the North Carolina Coastal Federation to see this project come to fruition."
  • Sea & Shoreline, LLC is a Florida-based aquatic restoration firm that restores fresh and saltwater habitats to healthy and self-sustaining ecosystems.
  • The North Carolina Coastal Federation is a member-supported 501(c)3 that focuses on protecting and restoring the North Carolina coast.

Nektar to Announce Financial Results for the Second Quarter 2022 on Thursday, August 4, 2022, After Close of U.S.-Based Financial Markets

Retrieved on: 
Tuesday, July 26, 2022
SAN, Inflammation, Home page, Nektar, NKTR, Review, Nektar Therapeutics, Investor, Therapy, Pharmaceutical industry, Online shopping

SAN FRANCISCO, July 26, 2022 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter 2022 on Thursday, August 4, 2022, after the close of U.S.-based financial markets.

Key Points: 
  • SAN FRANCISCO, July 26, 2022 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter 2022 on Thursday, August 4, 2022, after the close of U.S.-based financial markets.
  • Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.
  • The web broadcast of the conference call will be available for replay through September 4, 2022.
  • Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com .

AVANGRID Second Quarter 2022 Financial Results Available on Company’s Website

Retrieved on: 
Tuesday, July 26, 2022
Alternative Energy, Energy, Utilities, Oil, Gas, Ethisphere Institute, Avangrid, Environment, JUST, Capital, NYSE, Interest, AGR, Goal, Investor, Renewable energy

AVANGRID, Inc. (NYSE:AGR) posted its second quarter 2022 earnings release and presentation in the Investors section of the Companys website.

Key Points: 
  • AVANGRID, Inc. (NYSE:AGR) posted its second quarter 2022 earnings release and presentation in the Investors section of the Companys website.
  • In conjunction with the earnings release, AVANGRID will conduct a webcast conference call with financial analysts on Wednesday, July 27, 2022 beginning at 10:00 A.M.
  • About AVANGRID: AVANGRID, Inc. (NYSE: AGR) aspires to be the leading sustainable energy company in the United States.
  • In 2022, AVANGRID ranked second within the utility sector for its commitment to the environment and the communities it serves.

CTS Corporation to Participate at the Jefferies Industrial Conference

Retrieved on: 
Tuesday, July 26, 2022
Conference, Connect, NYSE, Webcast, EDT, Sense, GLOBE, CT Corporation, CTS, Investor, Online gambling, Medical imaging

LISLE, Ill., July 26, 2022 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) announced today that Kieran OSullivan, President and Chief Executive Officer, will be participating at the Jefferies Industrial Conference on August 9, 2022, at 8:00 a.m., (EDT) which will be held virtually.

Key Points: 
  • LISLE, Ill., July 26, 2022 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) announced today that Kieran OSullivan, President and Chief Executive Officer, will be participating at the Jefferies Industrial Conference on August 9, 2022, at 8:00 a.m., (EDT) which will be held virtually.
  • You may access a live webcast of the event using this link or from the Investors section of the CTS Corporation website at www.ctscorp.com .
  • CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move.
  • The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets.

SeaSpine to Present at the Canaccord Genuity 42nd Annual Global Growth Conference

Retrieved on: 
Tuesday, July 26, 2022
Surgeon, GLOBE, Canaccord Genuity, Spinal fusion, Software, Navigation, National Center for Spinal Disorders, NASDAQ, Conference, Company, Neurosurgery, MIS, Patient, SPNE, Investor

CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the Canaccord Genuity 42nd Annual Global Growth Conference on August 10, 2022 beginning at 8:00 AM ET.

Key Points: 
  • CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will present at the Canaccord Genuity 42nd Annual Global Growth Conference on August 10, 2022 beginning at 8:00 AM ET.
  • A live and archived webcast of the event will be available from the Investors section of the SeaSpine website at: www.seaspine.com .
  • SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders.
  • SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.

Uniti Group Inc. to Present at the Cowen 8th Annual Communications Infrastructure Summit

Retrieved on: 
Tuesday, July 26, 2022
Nasdaq, ROCK, Acquisition, Webcast, GLOBE, Solution, UNIT, Trust, Investor

LITTLE ROCK, Ark., July 26, 2022 (GLOBE NEWSWIRE) -- Uniti Group Inc. (Uniti) (Nasdaq: UNIT) announced today that its President and Chief Executive Officer, Kenny Gunderman, and Vice President, Finance and Investor Relations, Bill DiTullio, are scheduled to participate at the Cowen 8th Annual Communications Infrastructure Summit.

Key Points: 
  • LITTLE ROCK, Ark., July 26, 2022 (GLOBE NEWSWIRE) -- Uniti Group Inc. (Uniti) (Nasdaq: UNIT) announced today that its President and Chief Executive Officer, Kenny Gunderman, and Vice President, Finance and Investor Relations, Bill DiTullio, are scheduled to participate at the Cowen 8th Annual Communications Infrastructure Summit.
  • The webcast will be available for replay for a limited time on Unitis website following the presentation.
  • Uniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of fiber and other wireless solutions for the communications industry.
  • As of March 31, 2022, Uniti owns approximately 129,000 fiber route miles, 7.7 million fiber strand miles, and other communications real estate throughout the United States.